Periodic Reporting for period 2 - DECOD-Ag (Revolutionary Platform to Decipher Immunogenicity of Tumour Neoantigens- the Ultimate Targets for Future Immunotherapies to Eradicate Cancer)

Immunotherapy has revolutionised cancer treatment, providing survival benefits in patients with hard-to-treat tumours. Tragically, these benefits are unevenly distributed. Clinical efficacy varies dramatically between (and within) cancer types, and severe side-effects persist...